Related Experiment Video
Updated: Jul 3, 2026

Using Retinal Imaging to Study Dementia
Published on: November 6, 2017
Cardiovascular risk factors and dementia
Howard Fillit1, David T Nash, Tatjana Rundek
1Institute for the Study of Aging and the Alzheimer's Drug Discovery Foundation, New York, New York 10019, USA. hfillit@alzdiscovery.org
Insights
Managing cardiovascular disease (CVD) risk factors may prevent dementia. Effective treatment of hypertension and dyslipidemia, alongside lifestyle changes, shows promise in reducing cognitive decline and Alzheimer's disease risk.
Area of Science:
- Gerontology
- Neurology
- Cardiology
Background:
- Dementias, including Alzheimer's disease (AD), are prevalent in aging populations and pose a significant economic burden.
- Growing evidence links cardiovascular disease (CVD) risk factors to dementia development.
Purpose of the Study:
- To review the relationship between specific CVD risk factors and dementia.
- To discuss how dementia treatment strategies can incorporate CVD risk reduction.
Main Methods:
- Literature review focusing on cardiovascular risk factors and dementia (e.g., AD).
- Emphasis on clinical outcome studies of pharmacologically modifiable CVD risk factors' effects on dementia and cognitive impairment.
Main Results:
- Lifestyle factors (obesity, inactivity, smoking) are linked to increased dementia risk.
- Antihypertensive medications may reduce cognitive decline; statins show potential benefits.
- Hypertension, dyslipidemia, and diabetes mellitus are associated with cognitive decline.
Conclusions:
- Clinical management of CVD risk factors is crucial for potentially preventing cognitive decline and dementia.
- Patient compliance with CVD risk management recommendations is essential.
Background:
Dementias, such as Alzheimer's disease (AD) and vascular dementia, are disorders of aging populations and represent a significant economic burden. Evidence is accumulating to suggest that cardiovascular disease (CVD) risk factors may be instrumental in the development of dementia.
Objective:
The goal of this review was to discuss the relationship between specific CVD risk factors and dementia and how current treatment strategies for dementia should focus on reducing CVD risks.
Methods:
We conducted a review of the literature for the simultaneous presence of 2 major topics, cardiovascular risk factors and dementia (eg, AD). Special emphasis was placed on clinical outcome studies examining the effects of treatments of pharmacologically modifiable CVD risk factors on dementia and cognitive impairment.
Results:
Lifestyle risk factors for CVD, such as obesity, lack of exercise, smoking, and certain psychosocial factors, have been associated with an increased risk of cognitive decline and dementia. Some evidence suggests that effectively managing these factors may prevent cognitive decline/dementia. Randomized, placebo-controlled trials of antihypertensive medications have found that such therapy may reduce the risk of cognitive decline, and limited data suggest a benefit for patients with AD. Some small open-label and randomized clinical trials of statins have observed positive effects on cognitive function; larger studies of statins in patients with AD are ongoing. Although more research is needed, current evidence indicates an association between CVD risk factors--such as hypertension, dyslipidemia, and diabetes mellitus--and cognitive decline/dementia.
Conclusions:
From a clinical perspective, these data further support the rationale for physicians to provide effective management of CVD risk factors and for patients to be compliant with such recommendations to possibly prevent cognitive decline/dementia.
Related Concept Videos
Dementia l: Introduction
Dementia
The progression of dementia is generally gradual.
Alzheimer Disease l: Introduction
Coronary Artery Disease I: Introduction
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures